NCT07072728 - Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder
Clinical Trial in Abbotsford, Victoria
This study is assessing the efficacy and safety of NPX-5 in psilocybin-assisted psychotherapy for the treatment of adjustment disorder due to cancer diagnosis. Who is it for? This study is for people who are aged between 18 and 80 years old and suffer from anxiety after adjusting to an acutely stressful event of their cancer diagnosis. This is called adjustment disorder. Study details Participants in this study wi... Source record lists lead sponsor Psyence Australia Pty Ltd and overall status Recruiting.
Last verified: 2026-06-12